24 results
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
anti-bribery laws of European Union member states, such as the U.K. Bribery Act 2010. Infringement of these laws could result in substantial fines
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
Union. The provision of benefits or advantages to physicians is also governed by the national anti-bribery laws of European Union member states … , such as the U.K. Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment.
Payments made to physicians in certain
6-K
EX-1.1
EVAX
Evaxion Biotech A/S
4 Oct 22
Current report (foreign)
8:56am
Criminal Code (in Danish: Straffeloven), U.S. Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery or anti
424B4
k7f7hruqo68ekfv 7iqe
5 Nov 21
Prospectus supplement with pricing info
4:47pm
6-K
EX-1.1
q9fpb7u859bde 1vjnl
5 Nov 21
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
8:30am
F-1/A
9ofev3
3 Nov 21
Registration statement (foreign) (amended)
7:50am
F-1
lidtuovj7ts1
26 Oct 21
Registration statement (foreign)
7:02am
F-1
EX-1.1
af6otye3lunn
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EX-99.2
u275dr7w 96f0520pr
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am
DRS
t2q00neyjrr bb46zv
25 Jun 21
Draft registration statement
12:00am
20-F
q20ml2n5z2 gggj9vc
7 Apr 21
Annual report (foreign)
4:31pm
424B4
d3wbaskp70 ewow
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
oferpsf7
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
im5ge
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
EX-1.1
p9rxliq5pl6j 9feleo
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
m8s1n1w7nty9k
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
y6q24
8 Jan 21
Registration statement (foreign)
4:54pm